Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
1. Inventiva reported a loss of $1.84 per share, exceeding estimates by $1.43. 2. Quarterly sales of $5.050 million missed the consensus estimate of $5.310 million. 3. Shares fell 5.5% to $5.72 in pre-market trading due to disappointing results. 4. Broader market trends show positive futures, but IVA is down today. 5. Other biotech stocks are also experiencing significant declines in pre-market trading.